AULIN SHERRY
Insider CIK 1862144 · XENE Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2024-12-18 | 2024-12-19 | 9,334 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2024-12-18 | 2024-12-19 | 16,000 | — | $0 | 6,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2024-12-18 | 2024-12-19 | 7,199 | $41.23 | $296.8K | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2024-12-18 | 2024-12-19 | 11,510 | $41.19 | $474.1K | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2024-12-18 | 2024-12-19 | 9,334 | $9.44 | $88.1K | 9,334 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2024-12-18 | 2024-12-19 | 16,000 | $11.58 | $185.3K | 16,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | F Tax w/h | 2024-12-18 | 2024-12-19 | 4,490 | $41.28 | $185.3K | 11,510 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | F Tax w/h | 2024-12-18 | 2024-12-19 | 2,135 | $41.28 | $88.1K | 7,199 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2024-03-11 | 2024-03-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2023-03-10 | 2023-03-14 | 120,000 | — | $0 | 120,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2022-09-02 | 2022-09-07 | 813 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2022-09-02 | 2022-09-07 | 32 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2022-09-02 | 2022-09-07 | 9,000 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2022-09-02 | 2022-09-07 | 2,292 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2022-09-02 | 2022-09-07 | 6,511 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2022-09-02 | 2022-09-07 | 32 | $7.49 | $240 | 9,032 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2022-09-02 | 2022-09-07 | 9,000 | $9.44 | $85.0K | 9,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2022-09-02 | 2022-09-07 | 15,355 | $39.57 | $607.6K | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2022-09-02 | 2022-09-07 | 813 | $8.40 | $6.8K | 9,845 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | F Tax w/h | 2022-09-02 | 2022-09-07 | 3,293 | $39.53 | $130.2K | 15,355 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2022-09-02 | 2022-09-07 | 6,511 | $4.75 | $30.9K | 18,648 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2022-09-02 | 2022-09-07 | 2,292 | $3.10 | $7.1K | 12,137 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2022-03-10 | 2022-03-14 | 125,000 | — | $0 | 125,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2021-06-03 | 2021-06-03 | 100,000 | — | $0 | 100,000 | SEC↗ |